These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7125625)

  • 1. Yersinia enterocolitica: comparative in vitro activities of seven new beta-lactam antibiotics.
    Scribner RK; Marks MI; Weber A; Pai CH
    Antimicrob Agents Chemother; 1982 Jul; 22(1):140-1. PubMed ID: 7125625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of Yersinia enterocolitica to eight beta-lactam antibiotics and clavulanic acid.
    Gaspar MC; Soriano F
    J Antimicrob Chemother; 1981 Aug; 8(2):161-4. PubMed ID: 7275884
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro susceptibilities of 126 clinical isolates of Yersinia enterocolitica to 21 beta-lactam antibiotics.
    Hornstein MJ; Jupeau AM; Scavizzi MR; Philippon AM; Grimont PA
    Antimicrob Agents Chemother; 1985 May; 27(5):806-11. PubMed ID: 2990327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Yersinia enterocolitica: the influence of incubation temperature on antibiotic susceptibility, beta-lactamase activity and growth characteristics (author's transl)].
    Kist M; Sanabria de Isele E
    Zentralbl Bakteriol A; 1980 Aug; 247(3):353-63. PubMed ID: 6968487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibiotic sensitivity of Yersinia enterocolitica and Yersinia pseudotuberculosis isolated from patients with the jaundice form of acute hepatitis].
    Gurleva GG; Korganov IaN; Makarovskaia LN; Zosimenko VS; Popov VF
    Antibiotiki; 1982 Jan; 27(1):37-41. PubMed ID: 7059145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative activities of 13 beta-lactam antibiotics.
    Muytjens HL; van der Ros-van de Repe J
    Antimicrob Agents Chemother; 1982 Jun; 21(6):925-34. PubMed ID: 7114839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic susceptibilities of Yersinia enterocolitica and Y. intermedia isolates from aquatic environments.
    Tzelepi E; Arvanitidou M; Mavroidi A; Tsakris A
    J Med Microbiol; 1999 Feb; 48(2):157-160. PubMed ID: 9989643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro and in-vivo activities of beta-lactam antibiotics on Yersinia enterocolitica.
    Hornstein MJ; Alonso JM; Elbhar A; Scavizzi MR
    J Antimicrob Chemother; 1992 Apr; 29(4):456-9. PubMed ID: 1607334
    [No Abstract]   [Full Text] [Related]  

  • 9. Yersinia enterocolitica infection in a compromised host.
    Tay L; Wan YC
    Singapore Med J; 1979 Dec; 20(4):457-9. PubMed ID: 545711
    [No Abstract]   [Full Text] [Related]  

  • 10. Susceptibility profiles of Yersinia spp strains to beta-lactams and other major classes of antimicrobials.
    Zaremba M; Jaworowska J; Zaremba K; Borowski J
    J Chemother; 1989 Jul; 1(4 Suppl):319-22. PubMed ID: 16312420
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antimicrobial susceptibility of Yersinia enterocolitica and Yersinia pseudotuberculosis strains isolated from humans in Poland during 2004-2009].
    Szych J; Jakubczak A; Wardak S; Madajczak G
    Med Dosw Mikrobiol; 2009; 61(4):311-9. PubMed ID: 20201320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current problems regarding the sensitivity of Yersinia enterocolitica to chemotherapeutic agents].
    Zaremba M
    Postepy Hig Med Dosw; 1979; 33(3):301-24. PubMed ID: 390526
    [No Abstract]   [Full Text] [Related]  

  • 13. Yersinia enterocolitica: in vitro antimicrobial susceptibility.
    Raevuori M; Harvey SM; Pickett MJ; Martin WJ
    Antimicrob Agents Chemother; 1978 May; 13(5):888-90. PubMed ID: 666308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activities of new beta-lactam antibiotics against Acinetobacter spp.
    Garcia I; Fainstein V; LeBlanc B; Bodey GP
    Antimicrob Agents Chemother; 1983 Aug; 24(2):297-9. PubMed ID: 6638992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural antibiotic susceptibility and biochemical profiles of Yersinia enterocolitica-like strains: Y. bercovieri, Y. mollaretii, Y. aldovae and 'Y. ruckeri'.
    Stock I; Henrichfreise B; Wiedemann B
    J Med Microbiol; 2002 Jan; 51(1):56-69. PubMed ID: 11800473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of pathogenic Yersinia enterocolitica isolated in Canada from 1972 to 1990.
    Preston M; Brown S; Borczyk A; Riley G; Krishnan C
    Contrib Microbiol Immunol; 1995; 13():175-9. PubMed ID: 8833827
    [No Abstract]   [Full Text] [Related]  

  • 17. The first isolation of human Yersinia enterocolitica in Brazil: case report.
    Pizsolitto AC; Falcão DP; Shimizu MT; Galväo SH; Giraldini W
    Contrib Microbiol Immunol; 1979; 5():169-73. PubMed ID: 535375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibilities of Yersinia enterocolitica biotype 4, serotype O:3.
    Hammerberg S; Sorger S; Marks MI
    Antimicrob Agents Chemother; 1977 Mar; 11(3):566-8. PubMed ID: 856005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of Yersinia enterocolitica and Yersinia pseudotuberculosis from human specimens and their drug-resistance in the Niigata District of Japan.
    Kanazawa Y; Ikemura K
    Contrib Microbiol Immunol; 1979; 5():106-14. PubMed ID: 535368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The beta-lactamases and beta-lactam antibiotic susceptibility of Yersinia enterocolitica.
    Pham JN; Bell SM; Martin L; Carniel E
    J Antimicrob Chemother; 2000 Dec; 46(6):951-7. PubMed ID: 11102414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.